VJHemOnc is committed to improving our service to you

EHA 2020 | Daratumumab for patients with monoclonal gammopathy of renal significance

VJHemOnc is committed to improving our service to you

Efstathios Kastritis

Efstathios Kastritis, MD, of University of Athens School of Medicine, Athens, Greece, outlines the use of daratumumab-based therapy for patients with monoclonal gammopathy of renal significance. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter